Chemical Compound

Val-Cit-PAB-MMAE

CAS Registry Number 644981-35-1
Val-Cit-PAB-MMAE chemical structure
Primary Record

Val-Cit-PAB-MMAE

In stock
1,845 g
Purity
99.8 %
CAS
644981-35-1

Compound Identifiers & Properties

CAS
644981-35-1
PubChem CID
88914158
SMILES
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)OCC3=CC=C(C=C3)NC(=O)[C@H](CCCNC(=O)N)NC(=O)[C@H](C(C)C)N
Canonical SMILES
CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C)[C@@H](O)c1ccccc1)OC)N(C)C(=O)[C@@H](NC(=O)[C@H](C(C)C)N(C)C(=O)OCc1ccc(NC(=O)[C@H](CCCNC(N)=O)NC(=O)[C@@H](N)C(C)C)cc1)C(C)C

Names & Synonyms

  • Val-Cit-PAB-MMAE
  • 644981-35-1
  • VC-PAB-MMAE
  • LZF6UU93KP
  • RefChem:1100951
  • Val-Cit-PAB-MMAE (GMP)
  • N-PM-0008
  • orb1307265
  • SCHEMBL12435366
  • EX-A4151
  • BBF-05881
  • C58H94N10O12
  • MFCD25372036
  • AKOS040744007
  • CS-5780
  • HY-100374G
  • DA-48529
  • FV171750
  • MS-31988
  • SY047507
  • HY-100374
  • CS-0899246
  • J3.095.088G
  • E79123
  • A929370
  • F981957
  • [4-[[(2S)-2-[[(2S)-2-amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylcarbamate
  • 7-hydroxy-4-(trifluoromethyl)-4H-1-Benzopyran-4-one
  • 4H-1-Benzopyran-4-one,7-hydroxy-4-(trifluoromethyl)-
  • N-Methyl-N-[[[4-[[L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
  • (2R,3R)-N-[(alphaR,betaS)-alpha-Methyl-beta-hydroxyphenethyl]-2-methyl-3-[(2S)-1-[(3R,4S,5S)-3-methoxy-4-[methyl[N-[[4-[(Val-Cit-)amino]benzyloxy]carbonyl]-N-methyl-Val-Val-]amino]-5-methylheptanoyl]pyrrolidine-2-yl]-3-methoxypropionamide
  • [4-[[(2S)-2-[[(2S)-2-amino-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methyl N-[(1S)-1-[[(1S)-1-[[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenyl-ethyl]amino]-1-methoxy-2-methyl-3-oxo-propyl]pyrrolidin-1-yl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxo-butyl]-methyl-carbamoyl]-2-methyl-propyl]carbamoyl]-2-methyl-propyl]-N-methyl-carbamate
  • {4-[(2S)-2-[(2S)-2-AMINO-3-METHYLBUTANAMIDO]-5-(CARBAMOYLAMINO)PENTANAMIDO]PHENYL}METHYL N-[(1S)-1-{[(1S)-1-{[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-2-{[(1S,2R)-1-HYDROXY-1-PHENYLPROPAN-2-YL]CARBAMOYL}-1-METHOXY-2-METHYLETHYL]PYRROLIDIN-1-YL]-3-METHOXY-5-METHYL-1-OXOHEPTAN-4-YL](METHYL)CARBAMOYL}-2-METHYLPROPYL]CARBAMOYL}-2-METHYLPROPYL]-N-METHYLCARBAMATE
  • 4-((S)-2-((S)-2-Amino-3-methylbutanamido)-5-ureidopentanamido)benzyl ((S)-1-(((S)-1-(((3R,4S,5S)-1-((S)-2-((1R,2R)-3-(((1S,2R)-1-hydroxy-1-phenylpropan-2-yl)amino)-1-methoxy-2-methyl-3-oxopropyl)pyrrolidin-1-yl)-3-methoxy-5-methyl-1-oxoheptan-4-yl)(methyl)amino)-3-methyl-1-oxobutan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)(methyl)carbamate
  • L-Valinamide, N-methyl-N-[[[4-[[L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-
  • L-Valyl-N-{4-[(5S,8S,11S,12R)-11-[(2S)-2-butanyl]-12-(2-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenyl-2-propanyl]amino}-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl}-2-oxoethyl)-5,8-diisopropyl-4,10-dimethyl-3,6,9-trioxo-2,13-dioxa-4,7,10-triazatetradec-1-yl]phenyl}-N5-carbamoyl-L-ornithinamide
  • N/A